Guided Therapeutics (GTHP) Non-cash Items (2011 - 2021)

Guided Therapeutics (GTHP) has 11 years of Non-cash Items data on file, last reported at -$224000.0 in Q2 2021.

• For the quarter ending Q2 2021, Non-cash Items fell 103.53% year-over-year to -$224000.0; the trailing twelve-month figure through Jun 2021 stood at -$4.0 million (down 343.81% YoY), and the FY2020 full-year result was -$1.6 million, down 243.14% from the prior year.
• Non-cash Items slipped to -$224000.0 in Q2 2021, from $906000.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $6.5 million in Q4 2017 to a low of -$3.7 million in Q2 2018.
• A 5-year average of $409500.0 and a median of -$63500.0 in 2019 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items soared 1390.34% in 2017 and slumped 11334.48% in 2020, its largest moves.
• Tracing GTHP's Non-cash Items over 5 years: stood at $6.5 million in 2017, then sank by 62.55% to $2.4 million in 2018, then slumped by 152.96% to -$1.3 million in 2019, then slumped by 94.02% to -$2.5 million in 2020, then jumped by 91.03% to -$224000.0 in 2021.
• Business Quant data shows GTHP's Non-cash Items at -$224000.0 in Q2 2021, $906000.0 in Q1 2021, and -$2.5 million in Q4 2020.